Franz Bernard Humer's most recent trade in Allogene Therapeutics Inc was a trade of 95,400 Restricted Stock Unit done . Disclosure was reported to the exchange on June 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 95,400 | 95,400 | - | - | Restricted Stock Unit | |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 05 Dec 2024 | 9,221 | 307,507 (0%) | 0% | 2.2 | 19,917 | Common Stock |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 95,541 | 95,541 | - | - | Stock Option (Right to buy) | |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 61,475 | 316,728 (0%) | 0% | 0 | Common Stock | |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 30 May 2024 | 11,200 | 255,253 (0%) | 0% | 2.3 | 26,181 | Common Stock |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 74,561 | 266,453 (0%) | 0% | 0 | Common Stock | |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 44,178 | 191,892 (0%) | 0% | 0 | Common Stock | |
Allogene Therapeutics Inc | Franz Bernard Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 16,498 | 147,714 (0%) | 0% | 0 | Common Stock |